Skip to main content
. 2017 Oct 5;17:257. doi: 10.1186/s12872-017-0686-z

Fig. 1.

Fig. 1

Flow diagram of selection strategy. ACEI, angiotensin-converting enzyme inhibitor, ARB, angiotensin II receptor blocker